… for differences that may affect disease risk. Impact on Diagnosis/Treatment of Parkinson's Disease: Clarifying genetic risk factors will help in pre-clinical diagnosis and will help determine which individuals are … These specific genetic variants may provide further insight into the mechanism of how altered levels or dysfunctional …

… This critical biochemical process begins to malfunction early on in Parkinson’s disease (PD). Many laboratories are … with a tiny amount of a radioactive probe that enters into the brain and latches onto GBA. We will prepare … GBA dysfunction contributes to neurodegeneration. Impact on Diagnosis/Treatment of Parkinson’s disease:  Tools that …

… (recently diagnosed) PD patients and control volunteers. Researchers will collect data over three to five years, … is the first study of its kind to closely follow early PD and control subjects to determine whether collected … certain genetic mutations). The genetic component has grown into its own arm, now recruiting cohorts of PD patients and …

… This grant builds upon the research from a prior grant: Utilization of Aptamers to … funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF), we discovered a new type of molecule, … better understand where aptamer travels once it is injected into a pre-clinical model. Specifically, we will inject …

… and demonstrably improve their machine-learned ability for diagnosis and prognosis of  Parkinson’s disease (PD). … misfolded proteins in intracellular spaces can be diagnosed early when localized and cross-correlated with multimodal … of misfolded proteins and neuronal cell loss. Impact on Diagnosis/Treatment of Parkinson’s disease:  The inclusion …

… This grant builds upon the research from a prior grant: Kinase Activity in Lymphocytes … cell line originating from leukemia (blood cancer) research. The work will be extended to human biosamples, … kinase activity may become a peripheral biomarker for the diagnosis and follow up of those with PD. If LRRK2 …